Literature DB >> 28150091

Reliability and Validity of the Short Version of Udvalg for Kliniske Undersogelser in Antipsychotic Treatment.

Kun-Po Chen1,2, For-Wey Lung3,4,5.   

Abstract

The aim of this study was to develop a reliable and valid short version of the Udvalg for Kliniske Undersogelser (UKU) to efficiently evaluate the side effects of antipsychotics in patients with schizophrenia. This multi-site study included 10 hospitals, which included 331 inpatients and outpatients diagnosed with schizophrenia. UKU, Clinical Global Impression-Severity (CGI-S), Personal and Social Performance (PSP) and dosage of paliperidone were collected. The predictive validity of the UKU-short version, as well as that of the CGI-S, PSP and paliperidone dosages, was analyzed using structural equation modeling (SEM), latent growth models (LGM), and confirmatory factor analysis to test its content and construct validity. The UKU-short included nine-items of sedation, reduced sleep, rigidity, tremor, akathisia, headache, reduced salivation, constipation and orthostatic dizziness, and has good construct and content validity over time. Confirmatory factor analysis showed good construct validity, with the psychic, neurological and autonomic side effect dimensions having correlations between 0.60 and 0.71. The predictive validity of the short-version UKU for psychiatric symptoms (CGI-S), quality of life (PSP) and dosage showed that the effects of drug dosage were negligible, and only neurological side effects were associated with psychiatric symptoms and quality of life. The UKU-short showed good content, construct and predictive validity. It is a more time-efficient instrument than the original UKU. This study only included patients treated with paliperidone, larger scale studies is needed to validate the UKU-short in detection of side effects in routine clinical practice to prevent non-adherence in patients with schizophrenia.

Entities:  

Keywords:  Adherence; Atypical antipsychotics; Short version; Side effect; Udvalg for Kliniske Undersogelser (UKU)

Mesh:

Substances:

Year:  2017        PMID: 28150091     DOI: 10.1007/s11126-017-9494-y

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  28 in total

1.  Psychopharmacology: Perspectives on medication adherence and atypical antipsychotic medications.

Authors:  Dawn I Velligan; Francis Lam; Larry Ereshefsky; Alexander L Miller
Journal:  Psychiatr Serv       Date:  2003-05       Impact factor: 3.084

2.  Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis.

Authors:  Shaun M Eack; Christina E Newhill
Journal:  Schizophr Bull       Date:  2007-01-04       Impact factor: 9.306

3.  Predictive value of symptoms for quality of life in first-episode schizophrenia.

Authors:  Preeta Kaur Chugh; Harmeet S Rehan; K E S Unni; Ravinder K Sah
Journal:  Nord J Psychiatry       Date:  2012-05-16       Impact factor: 2.202

4.  Priapism associated with typical and atypical antipsychotic medications.

Authors:  Chien-Shu Wang; Wei-Tsung Kao; Chian-Dar Chen; Yu-Ping Tung; For-Wey Lung
Journal:  Int Clin Psychopharmacol       Date:  2006-07       Impact factor: 1.659

5.  The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine.

Authors:  Steven G Potkin; Per T Thyrum; Gustavo Alva; Rimal Bera; Chiao Yeh; Lisa A Arvanitis
Journal:  J Clin Psychopharmacol       Date:  2002-04       Impact factor: 3.153

6.  A conceptual model of quality of life in schizophrenia: description and preliminary clinical validation.

Authors:  A G Awad; L N Voruganti; R J Heslegrave
Journal:  Qual Life Res       Date:  1997-01       Impact factor: 4.147

7.  Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: a discriminant function analysis.

Authors:  G Donohoe; N Owens; C O'Donnell; T Burke; L Moore; A Tobin; E O'Callaghan
Journal:  Eur Psychiatry       Date:  2001-08       Impact factor: 5.361

8.  Association of typical versus atypical antipsychotics with symptoms and quality of life in schizophrenia.

Authors:  Koichiro Fujimaki; Terumichi Takahashi; Shigeru Morinobu
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

9.  Analysis of Adverse Drug Reactions of Atypical Antipsychotic Drugs in Psychiatry OPD.

Authors:  Kiran G Piparva; J G Buch; Kalpesh V Chandrani
Journal:  Indian J Psychol Med       Date:  2011-07

10.  The relationship between sex life satisfaction and job stress of married nurses.

Authors:  Hsiu-Hui Lee; For-Wey Lung; Pei-Rong Lee; Wei-Tsung Kao; Yu-Lan Lee
Journal:  BMC Res Notes       Date:  2012-08-19
View more
  2 in total

1.  Gender Differences in the First-Year Antipsychotic Treatment for Chinese First-Episode Schizophrenia.

Authors:  Chengcheng Pu; Bingjie Huang; Tianhang Zhou; Zhang Cheng; Yi Wang; Chuan Shi; Xin Yu
Journal:  Neuropsychiatr Dis Treat       Date:  2020-12-17       Impact factor: 2.570

2.  Unveiling the Metabolic Profile of First-Episode Drug-Naïve Schizophrenia Patients: Baseline Characteristics of a Longitudinal Study Among Han Chinese.

Authors:  Qi Zhang; Hui He; Xia Bai; Liping Jiang; Wei Chen; Xiaoying Zeng; Yanjia Li; Antonio L Teixeira; Jing Dai
Journal:  Front Psychiatry       Date:  2021-07-09       Impact factor: 4.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.